Quantcast
Last updated on April 20, 2014 at 5:20 EDT

Latest Vanderbilt University Medical Center Stories

2009-02-03 16:47:53

A team of Vanderbilt University Medical Center investigators has developed a group of chemical compounds that could represent a new class of drugs for treating cancer.The compounds are the first selective inhibitors of the protein phospholipase D (PLD), an enzyme that has been implicated in multiple human cancers including breast, renal, gastric and colorectal.The new inhibitors, reported in the February issue of Nature Chemical Biology, block the invasive migration of breast cancer cells,...

2009-01-27 16:36:26

Vanderbilt University Medical Center investigators have found a surprising link between brain iron levels and serotonin, a neurotransmitter involved in neuropsychiatric conditions ranging from autism to major depression. Appearing in the Proceedings of the National Academy of Sciences this week, the study by Randy Blakely, Ph.D., and colleagues also demonstrates the utility of a powerful in silico approach for discovering novel traits linked to subtle genetic variation. The serotonin...

2008-10-31 12:00:32

InteRNA Technologies and VU university medical center in Amsterdam have signed a framework research agreement to develop microRNA-based diagnostics and therapeutics for cancer using InteRNA's proprietary library of miRNAs. Under the research collaboration, InteRNA will apply its unique lentiviral-based miRNA overexpression library in multi-parametric, high-throughput screening assays to identify the biological role of individual miRNAs and novel therapeutic targets in leukemia, colon,...

2008-10-30 09:00:41

BILTHOVEN and AMSTERDAM, The Netherlands, October 30 /PRNewswire/ -- InteRNA Technologies B.V. and VU university medical center in Amsterdam, VUmc, announce today the signing of a framework research agreement to develop microRNA (miRNA)-based diagnostics and therapeutics for cancer using InteRNA's proprietary library of miRNAs. Under the research collaboration, InteRNA will apply its unique lentiviral-based miRNA overexpression library in multi-parametric, high-throughput screening assays...

2008-09-05 09:00:09

Sprint plans to increase wireless connectivity at the Vanderbilt University and Medical Center by upgrading the university's existing communication system, including additional network coverage on both the Nationwide Sprint Network and the Nextel National Network covering eight buildings on the campus. In 2004, Sprint installed an in-building system throughout the medical center at the university, including four CDMA and two iDEN towers on campus, a Sprint retail location on-site, and an...

2008-09-03 12:00:08

Students, faculty, staff and visitors at Vanderbilt University and Medical Center (VUMC) will now have additional wireless connectivity on campus. Sprint (NYSE:S), a long-time provider of wireless services to this campus, will provide an upgrade to the existing system, including additional network coverage on both the Nationwide Sprint Network and the Nextel National Network covering eight buildings on campus, an area of 3.8 million square feet. In 2004, Sprint installed an in-building...

2008-07-30 18:00:54

Vanderbilt Medical Center, the birthplace of technology commercialized by Informatics Corporation of America (ICA; www.icainformatics.com), has been named to the honor roll of America's best hospitals and ranked 15th overall in the survey published in U.S. News and World Report (7/21-28/08). ICA provides clinicians with a single technology solution for accessing, evaluating and acting upon patient information across disparate systems. Harry Jacobson, M.D., Vice Chancellor for Health...

54fc15e0b4ed06ce3744886741bfad701
2008-02-25 09:35:00

A technique that specifically "tags" tumors responding to chemotherapy may offer a new strategy for determining a cancer treatment's effectiveness within days of starting treatment, according to a new study by Vanderbilt-Ingram Cancer Center investigators.Appearing online ahead of print in Nature Medicine, the researchers report the identification of a small protein that specifically recognizes tumors responding to chemotherapy. They show that the protein, when tagged with a light-emitting...

2007-12-05 18:00:12

LYON, France, Dec. 5, 2007 (PRIME NEWSWIRE) -- EDAP TMS S.A. (Nasdaq:EDAP), the global leader in High Intensity Focused Ultrasound treatment of prostate cancer, announced the launch of Ablatherm HIFU treatments at Vanderbilt University Medical Center, Nashville, TN. The treatments are part of EDAP's ongoing Phase II/III U.S. Clinical Study program seeking FDA approval as the first HIFU device for prostate cancer in the United States. First patient was successfully treated with...

2005-10-28 13:41:22

Nashville (Tenn.) - Vanderbilt University Medical Center is enrolling volunteers in a study to test a new vaccine that targets avian flu, the first such vaccine against the virus. The Vanderbilt trial, led by Kathryn Edwards, M.D., will test the new vaccine in nearly 100 individuals 65 years of age and over. It is the second phase of a national study led by the National Institute of Allergy and Infectious Diseases. The first phase of the avian flu vaccine trial, conducted at various other...